Effect of intravitreal bevacizumab on iris vessels in neovascular glaucoma patients

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 248, Issue 11, 2010, Pages 1601-1609

  Sugimoto, Yosuke ^a   Mochizuki, Hideki ^a   Okumichi, Hideaki ^a   Takumida, Masaya ^a   Takamatsu, Michiya ^a   Kawamata, Seiichi ^b   Kiuchi, Yoshiaki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Bevacizumab; Iris; Neovascular glaucoma; Pathologic neovascularization; Vascular endothelial growth factor

Indexed keywords

ANTICOAGULANT AGENT; BEVACIZUMAB; CD34 ANTIGEN; MITOMYCIN C; MONOCLONAL ANTIBODY; VASCULOTROPIN;

ADULT; AGED; ANTERIOR EYE CHAMBER; ANTIANGIOGENIC ACTIVITY; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBRIN FORMATION; HUMAN; HYPHEMA; IMMUNOHISTOCHEMISTRY; IRIS BLOOD VESSEL; IRIS RUBEOSIS; IRIS STROMA; MALE; NEOVASCULAR GLAUCOMA; OPEN ANGLE GLAUCOMA; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; SINGLE DRUG DOSE; SLIT LAMP; STROMA; SURGICAL TECHNIQUE; TRABECULECTOMY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD34; FEMALE; GLAUCOMA, NEOVASCULAR; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAVITREAL INJECTIONS; IRIS; MALE; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77957664372     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-010-1406-x     Document Type: Article

References (28)

1. S Ishida K Shinoda S Kawashima Y Oguchi Y Okada E Ikeda 2000 Coexpression of VEGF receptors VEGF-R2 and neuropilin-1 in proliferative diabetic retinopathy Invest Ophthalmol Vis Sci 41 1649 1656 1:STN:280: DC%2BD3czgt1ajtg%3D%3D 10845581
2. BI Rini S Halabi J Taylor EJ Small RL Schilsky Cancer and Leukemia Group B 2004 Cancer and Leukemia Group B 90206: a randomized phase III trial of interferon-alpha or interferon-alpha plus anti-vascular endothelial growth factor antibody (bevacizumab) in metastatic renal cell carcinoma Clin Cancer Res 10 2584 2586 1:CAS:528:DC%2BD2cXjt1Cltrk%3D 10.1158/1078-0432.CCR-03-0605 15102658
3. RF Spaide YL Fisher 2006 Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage Retina 26 275 278 10.1097/00006982-200603000-00004 16508426
4. R Lazic N Gabric 2007 Intravitreally administered bevacizumab (Avastin) in minimally classic and occult choroidal neovascularization secondary to age-related macular degeneration Graefes Arch Clin Exp Ophthalmol 245 1 68 73 1:CAS:528:DC%2BD28Xht1KgtrbP 10.1007/s00417-006-0466-4 17111146
5. Z Vatavuk G Bencic Z Mandic 2007 Intravitreal bevacizumab for neovascular glaucoma following central retinal artery occlusion Eur J Ophthalmol 17 269 271 1:STN:280:DC%2BD2s3htV2qtg%3D%3D 17415704
6. A Travassos S Teixeira P Ferreira I Regadas AS Travassos FE Esperancinha, et al. 2007 Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity Ophthalmic Surg Lasers Imaging 38 233 237 17552391
7. JO Mason 3rd MA Albert Jr R Vail 2006 Intravitreal bevacizumab (Avastin) for refractory pseudophakic cystoid macular edema Retina 26 356 357 10.1097/00006982-200603000-00018 16508440
8. RL Avery 2006 Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment Retina 26 352 354 10.1097/00006982-200603000-00016 16508438
9. FH Davidorf JG Mouser RJ Derick 2006 Rapid improvement of rubeosis iridis from a single bevacizumab (Avastin) injection Retina 26 354 356 10.1097/00006982-200603000-00017 16508439
10. S Grisanti S Bieste S Peters O Tatar F Ziemssen KU Bartz-Schmidt 2006 Intracameral bevacizumab for iris rubeosis Am J Ophthalmol 142 158 160 1:CAS:528:DC%2BD28Xms1Gktbo%3D 10.1016/j.ajo.2006.02.045 16815268
11. ME Iliev D Domingo U Wolf-Schnurrbursch S Wolf G Sarra 2006 Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma Am J Ophthalmol 142 1054 1056 1:CAS:528:DC%2BD28Xht12msLfM 10.1016/j.ajo.2006.06.066 17157590
12. JB Jonas UH Spandau F Schlichtenbrede 2007 Intravitreal bevacizumab for filtering surgery Opthalmic Res 39 121 122 1:CAS:528:DC%2BD2sXivValtr8%3D 10.1159/000099248
13. MY Kahook JS Schuman RJ Noecker 2006 Intravitreal bevacizumab in a patient with neovascular glaucoma Ophthalmic Surg Lasers Imaging 37 144 146 16583637
14. JO Mason 3rd MA Albert Jr A Mays R Vail 2006 Regression of neovascular iris vessels by intravitreal injection of bevacizumab Retina 26 839 841 10.1097/01.iae.0000230425.31296.3b 16963866
15. PJ Silva R Jorge CR Alves ML Rodrigues IU Scott 2006 Short-term results of intravitreal bevacizumab (Avastin) on anterior segment neovascularization in neovascular glaucoma Acta Ophthalmol Scand 84 556 557 10.1111/j.1600-0420.2006. 00731.x
16. S Yazdani K Hendi M Pakravan 2007 Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma J Glaucoma 16 437 439 10.1097/IJG. 0b013e3180457c47 17700285
17. AN Witmer BC van Blijswijk CJ van Noorden GF Vrensen RO Schlingemann 2004 In vivo angiogenic phenotype of endothelial cells and pericytes induced by vascular endothelial growth factor-A J Histochem Cytochem 52 39 52 1:CAS:528:DC%2BD2cXhtVWquw%3D%3D 14688216
18. A Iriyama YN Chen Y Tamaki Y Yanagi 2007 Effect of anti VEGF-antibody on retinal ganglion cells in rats Br J Opthalmol 91 1230 1233 10.1136/bjo.2007. 117309
19. SJ Bakri D Cameron CA McCannel JS Pulido RJ Marler 2006 Absence of histologic retinal toxicity of intravitreal bevacizumab in a rabbit model Am J Ophthalmol 142 162 164 1:CAS:528:DC%2BD28Xms1Gktbg%3D 10.1016/j.ajo.2006.03.058 16815270
20. S Peters P Heiduschka S Julien F Ziemssen H Fietz KU Bartz-Schmidt 2007 Ultrastructural findings in the primate eye after intravitreal injection of bevacizumab Am J Opthalmol 143 995 1002 1:CAS:528:DC%2BD2sXlvVakur4%3D 10.1016/j.ajo.2007.03.007
21. JA Sivak-Callcott DM O'Day JD Gass JC Tsai 2001 Evidence-based recommendations for the diagnosis and treatment of neovascular glaucoma Ophthalmology 108 1767 1778 1:STN:280:DC%2BD3MrjsVGlsQ%3D%3D 10.1016/S0161-6420(01)00775-8 11581047
22. A Miki Y Oshima Y Otori M Kamei Y Tano 2008 Efficacy of intravitreal bevacizumab as adjunctive treatment with pars plana vitrectomy, endolaser photocoagulation, and trabeculectomy for neovascular glaucoma Br J Opthalmol 92 1431 1433 1:STN:280:DC%2BD1cnisF2ktQ%3D%3D 10.1136/bjo.2007.129833
23. Y Kiuchi R Sugimoto K Nakae Y Saito S Ito 2006 Trabeculectomy with itomycin C for treatment of neovascular glaucoma in diabetic patients Ophthalmologica 220 6 383 388 1:CAS:528:DC%2BD28XhtFymtLrJ 10.1159/000095865 17095884
24. U Elgin N Berker A Batman T Simsek B Cankaya 2006 Trabeculectomy with mitomycin C combined with direct cauterization of peripheral iris in the management of neovascular glaucoma J Glaucoma 15 5 466 470 10.1097/01.ijg. 0000212270.27359.64 16988612
25. Y Kiuchi K Nakae Y Saito S Ito N Ito 2006 Pars plana vitrectomy and panretinal photocoagulation combined with trabeculectomy for successful treatment of neovascular glaucoma Graefes Arch Clin Exp Ophthalmol 244 12 1627 1632 10.1007/s00417-006-0321-7 16639623
26. T Wakabayashi Y Oshima H Sakaguchi Y Ikuno A Miki F Gomi, et al. 2008 Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases Ophthalmology 115 1571 1580 10.1016/j.ophtha.2008.02.026 18440643
27. S Kaempf S Johnen AK Salz A Weinberger P Walter G Thumann 2008 Effects of bevacizumab (Avastin) on retinal cells in organotypic culture Invest Ophthalmol Vis Sci 49 7 3164 3171 10.1167/iovs.07-1265 18344448
28. Y Saito T Higashide H Takeda S Ohkubo K Sugiyama 2010 Beneficial effects of preoperative intravitreal bevacizumab on trabeculectomy outcomes in neovascular glaucoma Acta Ophthalmologica 88 1 96 102 1:CAS:528: DC%2BC3cXjs1GrtbY%3D 10.1111/j.1755-3768.2009.01648.x 19775309